ID   ADHX_HUMAN              Reviewed;         374 AA.
AC   P11766; Q6FHR2;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 192.
DE   RecName: Full=Alcohol dehydrogenase class-3;
DE            EC=1.1.1.1;
DE   AltName: Full=Alcohol dehydrogenase 5;
DE   AltName: Full=Alcohol dehydrogenase class chi chain;
DE   AltName: Full=Alcohol dehydrogenase class-III;
DE   AltName: Full=Glutathione-dependent formaldehyde dehydrogenase;
DE            Short=FALDH;
DE            Short=FDH;
DE            Short=GSH-FDH;
DE            EC=1.1.1.-;
DE   AltName: Full=S-(hydroxymethyl)glutathione dehydrogenase;
DE            EC=1.1.1.284;
GN   Name=ADH5 {ECO:0000312|HGNC:HGNC:253}; Synonyms=ADHX, FDH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2818582; DOI=10.1016/0006-291X(89)91507-6;
RA   Sharma C.P., Fox E.A., Holmquist B., Joernvall H., Vallee B.L.;
RT   "cDNA sequence of human class III alcohol dehydrogenase.";
RL   Biochem. Biophys. Res. Commun. 164:631-637(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2679557; DOI=10.1016/0006-291X(89)91741-5;
RA   Giri P.R., Krug J.F., Kozak C., Moretti T., O'Brien S.J.,
RA   Seuanez H.N., Goldman D.;
RT   "Cloning and comparative mapping of a human class III (chi) alcohol
RT   dehydrogenase cDNA.";
RL   Biochem. Biophys. Res. Commun. 164:453-460(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1446828; DOI=10.1016/0378-1119(92)90135-C;
RA   Hur M.W., Edenberg H.J.;
RT   "Cloning and characterization of the ADH5 gene encoding human alcohol
RT   dehydrogenase 5, formaldehyde dehydrogenase.";
RL   Gene 121:305-311(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-163 AND ILE-309.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-374, AND COFACTOR.
RC   TISSUE=Liver;
RX   PubMed=3365377; DOI=10.1021/bi00404a009;
RA   Kaiser R., Holmquist B., Hempel J., Vallee B.L., Joernvall H.;
RT   "Class III human liver alcohol dehydrogenase: a novel structural type
RT   equidistantly related to the class I and class II enzymes.";
RL   Biochemistry 27:1132-1140(1988).
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, AND MUTAGENESIS OF ARG-115.
RX   PubMed=8494891; DOI=10.1021/bi00070a024;
RA   Holmquist B., Moulis J.-M., Engeland K., Vallee B.L.;
RT   "Role of arginine 115 in fatty acid activation and formaldehyde
RT   dehydrogenase activity of human class III alcohol dehydrogenase.";
RL   Biochemistry 32:5139-5144(1993).
RN   [10]
RP   MUTAGENESIS OF ARG-115.
RX   PubMed=8460164; DOI=10.1073/pnas.90.6.2491;
RA   Engeland K., Hoeoeg J.-O., Holmquist B., Estonius M., Joernvall H.,
RA   Vallee B.L.;
RT   "Mutation of Arg-115 of human class III alcohol dehydrogenase: a
RT   binding site required for formaldehyde dehydrogenase activity and
RT   fatty acid activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:2491-2494(1993).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324 AND SER-351, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=9018047; DOI=10.1006/jmbi.1996.0731;
RA   Yang Z.-N., Bosron W.F., Hurley T.D.;
RT   "Structure of human chi chi alcohol dehydrogenase: a glutathione-
RT   dependent formaldehyde dehydrogenase.";
RL   J. Mol. Biol. 265:330-343(1997).
CC   -!- FUNCTION: Class-III ADH is remarkably ineffective in oxidizing
CC       ethanol, but it readily catalyzes the oxidation of long-chain
CC       primary alcohols and the oxidation of S-(hydroxymethyl)
CC       glutathione.
CC   -!- CATALYTIC ACTIVITY: An alcohol + NAD(+) = an aldehyde or ketone +
CC       NADH.
CC   -!- CATALYTIC ACTIVITY: S-(hydroxymethyl)glutathione + NAD(P)(+) = S-
CC       formylglutathione + NAD(P)H.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:3365377};
CC       Note=Binds 2 Zn(2+) ions per subunit.
CC       {ECO:0000269|PubMed:3365377};
CC   -!- SUBUNIT: Homodimer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: There are 7 different ADH's isozymes in human:
CC       three belongs to class-I: alpha, beta, and gamma, one to class-II:
CC       pi, one to class-III: chi, one to class-IV: ADH7 and one to class-
CC       V: ADH6.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. Class-III subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/adh5/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M30471; AAA79018.1; -; mRNA.
DR   EMBL; M29872; AAA51597.1; -; mRNA.
DR   EMBL; M81118; AAA51596.1; -; Genomic_DNA.
DR   EMBL; M81112; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; M81113; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; M81114; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; M81115; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; M81116; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; M81117; AAA51596.1; JOINED; Genomic_DNA.
DR   EMBL; CR541689; CAG46490.1; -; mRNA.
DR   EMBL; BT019832; AAV38635.1; -; mRNA.
DR   EMBL; AY987960; AAX81412.1; -; Genomic_DNA.
DR   EMBL; BC014665; AAH14665.1; -; mRNA.
DR   CCDS; CCDS47111.1; -.
DR   PIR; JH0789; DEHUC2.
DR   RefSeq; NP_000662.3; NM_000671.4.
DR   UniGene; Hs.78989; -.
DR   PDB; 1M6H; X-ray; 2.00 A; A/B=2-374.
DR   PDB; 1M6W; X-ray; 2.30 A; A/B=2-374.
DR   PDB; 1MA0; X-ray; 2.30 A; A/B=2-374.
DR   PDB; 1MC5; X-ray; 2.60 A; A/B=1-374.
DR   PDB; 1MP0; X-ray; 2.20 A; A/B=2-374.
DR   PDB; 1TEH; X-ray; 2.70 A; A/B=2-374.
DR   PDB; 2FZE; X-ray; 1.90 A; A/B=2-374.
DR   PDB; 2FZW; X-ray; 1.84 A; A/B=2-374.
DR   PDB; 3QJ5; X-ray; 1.90 A; A/B=2-374.
DR   PDBsum; 1M6H; -.
DR   PDBsum; 1M6W; -.
DR   PDBsum; 1MA0; -.
DR   PDBsum; 1MC5; -.
DR   PDBsum; 1MP0; -.
DR   PDBsum; 1TEH; -.
DR   PDBsum; 2FZE; -.
DR   PDBsum; 2FZW; -.
DR   PDBsum; 3QJ5; -.
DR   ProteinModelPortal; P11766; -.
DR   SMR; P11766; -.
DR   BioGrid; 106640; 18.
DR   IntAct; P11766; 8.
DR   MINT; MINT-1374117; -.
DR   STRING; 9606.ENSP00000296412; -.
DR   BindingDB; P11766; -.
DR   ChEMBL; CHEMBL4116; -.
DR   DrugBank; DB03704; 12-Hydroxydodecanoic Acid.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB03017; Lauric Acid.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB04153; S-Hydroxymethyl Glutathione.
DR   SwissLipids; SLP:000000500; -.
DR   iPTMnet; P11766; -.
DR   PhosphoSitePlus; P11766; -.
DR   SwissPalm; P11766; -.
DR   DMDM; 113408; -.
DR   REPRODUCTION-2DPAGE; IPI00746777; -.
DR   EPD; P11766; -.
DR   PaxDb; P11766; -.
DR   PeptideAtlas; P11766; -.
DR   PRIDE; P11766; -.
DR   DNASU; 128; -.
DR   Ensembl; ENST00000296412; ENSP00000296412; ENSG00000197894.
DR   GeneID; 128; -.
DR   KEGG; hsa:128; -.
DR   CTD; 128; -.
DR   DisGeNET; 128; -.
DR   GeneCards; ADH5; -.
DR   HGNC; HGNC:253; ADH5.
DR   HPA; HPA044578; -.
DR   HPA; HPA061919; -.
DR   MalaCards; ADH5; -.
DR   MIM; 103710; gene.
DR   neXtProt; NX_P11766; -.
DR   OpenTargets; ENSG00000197894; -.
DR   PharmGKB; PA24574; -.
DR   eggNOG; KOG0022; Eukaryota.
DR   eggNOG; COG1062; LUCA.
DR   GeneTree; ENSGT00430000030800; -.
DR   HOGENOM; HOG000294674; -.
DR   HOVERGEN; HBG000195; -.
DR   InParanoid; P11766; -.
DR   KO; K00121; -.
DR   OMA; NPGREAM; -.
DR   OrthoDB; EOG091G08N3; -.
DR   PhylomeDB; P11766; -.
DR   TreeFam; TF300429; -.
DR   Reactome; R-HSA-71384; Ethanol oxidation.
DR   SABIO-RK; P11766; -.
DR   ChiTaRS; ADH5; human.
DR   EvolutionaryTrace; P11766; -.
DR   GeneWiki; ADH5; -.
DR   GenomeRNAi; 128; -.
DR   PRO; PR:P11766; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000197894; -.
DR   CleanEx; HS_ADH5; -.
DR   ExpressionAtlas; P11766; baseline and differential.
DR   Genevisible; P11766; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0004022; F:alcohol dehydrogenase (NAD) activity; IEA:UniProtKB-EC.
DR   GO; GO:0009055; F:electron carrier activity; TAS:UniProtKB.
DR   GO; GO:0005504; F:fatty acid binding; IDA:UniProtKB.
DR   GO; GO:0018467; F:formaldehyde dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0051903; F:S-(hydroxymethyl)glutathione dehydrogenase activity; TAS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006069; P:ethanol oxidation; TAS:Reactome.
DR   GO; GO:0046294; P:formaldehyde catabolic process; IEA:Ensembl.
DR   GO; GO:0018119; P:peptidyl-cysteine S-nitrosylation; IEA:Ensembl.
DR   GO; GO:0045777; P:positive regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0003016; P:respiratory system process; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0051409; P:response to nitrosative stress; IEA:Ensembl.
DR   GO; GO:0051775; P:response to redox state; IDA:UniProtKB.
DR   GO; GO:0001523; P:retinoid metabolic process; IEA:Ensembl.
DR   CDD; cd08300; alcohol_DH_class_III; 1.
DR   InterPro; IPR014183; ADH_3.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SUPFAM; SSF50129; SSF50129; 2.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR02818; adh_III_F_hyde; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Metal-binding; NAD; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:3365377}.
FT   CHAIN         2    374       Alcohol dehydrogenase class-3.
FT                                /FTId=PRO_0000160759.
FT   METAL        45     45       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:3365377}.
FT   METAL        67     67       Zinc 1; catalytic.
FT                                {ECO:0000269|PubMed:3365377}.
FT   METAL        97     97       Zinc 2. {ECO:0000269|PubMed:3365377}.
FT   METAL       100    100       Zinc 2. {ECO:0000269|PubMed:3365377}.
FT   METAL       103    103       Zinc 2. {ECO:0000269|PubMed:3365377}.
FT   METAL       111    111       Zinc 2. {ECO:0000269|PubMed:3365377}.
FT   METAL       174    174       Zinc 1; catalytic.
FT   SITE        115    115       Important for FDH activity and activation
FT                                by fatty acids.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     233    233       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P28474}.
FT   MOD_RES     247    247       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     315    315       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P28474}.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     351    351       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     163    163       L -> S (in dbSNP:rs28730623).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025823.
FT   VARIANT     309    309       V -> I (in dbSNP:rs28730628).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_025824.
FT   VARIANT     353    353       D -> E (in dbSNP:rs16996593).
FT                                /FTId=VAR_048199.
FT   MUTAGEN     115    115       R->A,D: Loss of FDH activity and loss of
FT                                activation by fatty acids.
FT                                {ECO:0000269|PubMed:8460164,
FT                                ECO:0000269|PubMed:8494891}.
FT   CONFLICT    167    167       D -> Y (in Ref. 2; AAA51597).
FT                                {ECO:0000305}.
FT   CONFLICT    246    246       F -> L (in Ref. 2; AAA51597).
FT                                {ECO:0000305}.
FT   STRAND        6     13       {ECO:0000244|PDB:2FZW}.
FT   STRAND       21     27       {ECO:0000244|PDB:2FZW}.
FT   STRAND       34     43       {ECO:0000244|PDB:2FZW}.
FT   HELIX        46     52       {ECO:0000244|PDB:2FZW}.
FT   STRAND       61     63       {ECO:0000244|PDB:2FZW}.
FT   STRAND       68     76       {ECO:0000244|PDB:2FZW}.
FT   STRAND       88     91       {ECO:0000244|PDB:2FZW}.
FT   STRAND       98    100       {ECO:0000244|PDB:3QJ5}.
FT   HELIX       101    104       {ECO:0000244|PDB:2FZW}.
FT   HELIX       115    119       {ECO:0000244|PDB:2FZW}.
FT   STRAND      129    132       {ECO:0000244|PDB:2FZW}.
FT   STRAND      135    138       {ECO:0000244|PDB:2FZW}.
FT   TURN        141    143       {ECO:0000244|PDB:2FZW}.
FT   STRAND      146    153       {ECO:0000244|PDB:2FZW}.
FT   HELIX       154    156       {ECO:0000244|PDB:2FZW}.
FT   STRAND      157    159       {ECO:0000244|PDB:2FZW}.
FT   HELIX       166    169       {ECO:0000244|PDB:2FZW}.
FT   HELIX       170    173       {ECO:0000244|PDB:2FZW}.
FT   HELIX       175    184       {ECO:0000244|PDB:2FZW}.
FT   TURN        185    187       {ECO:0000244|PDB:2FZW}.
FT   STRAND      194    198       {ECO:0000244|PDB:2FZW}.
FT   HELIX       202    214       {ECO:0000244|PDB:2FZW}.
FT   STRAND      217    222       {ECO:0000244|PDB:2FZW}.
FT   HELIX       226    228       {ECO:0000244|PDB:2FZW}.
FT   HELIX       229    235       {ECO:0000244|PDB:2FZW}.
FT   STRAND      238    241       {ECO:0000244|PDB:2FZW}.
FT   HELIX       243    245       {ECO:0000244|PDB:2FZW}.
FT   HELIX       250    257       {ECO:0000244|PDB:2FZW}.
FT   STRAND      262    267       {ECO:0000244|PDB:2FZW}.
FT   HELIX       272    280       {ECO:0000244|PDB:2FZW}.
FT   TURN        284    286       {ECO:0000244|PDB:2FZW}.
FT   STRAND      288    291       {ECO:0000244|PDB:2FZW}.
FT   STRAND      301    303       {ECO:0000244|PDB:2FZW}.
FT   HELIX       306    309       {ECO:0000244|PDB:2FZW}.
FT   STRAND      313    316       {ECO:0000244|PDB:2FZW}.
FT   HELIX       319    321       {ECO:0000244|PDB:2FZW}.
FT   HELIX       324    336       {ECO:0000244|PDB:2FZW}.
FT   HELIX       343    345       {ECO:0000244|PDB:2FZW}.
FT   STRAND      346    351       {ECO:0000244|PDB:2FZW}.
FT   HELIX       352    354       {ECO:0000244|PDB:2FZW}.
FT   HELIX       355    363       {ECO:0000244|PDB:2FZW}.
FT   STRAND      368    373       {ECO:0000244|PDB:2FZW}.
SQ   SEQUENCE   374 AA;  39724 MW;  F4F823B4A609C952 CRC64;
     MANEVIKCKA AVAWEAGKPL SIEEIEVAPP KAHEVRIKII ATAVCHTDAY TLSGADPEGC
     FPVILGHEGA GIVESVGEGV TKLKAGDTVI PLYIPQCGEC KFCLNPKTNL CQKIRVTQGK
     GLMPDGTSRF TCKGKTILHY MGTSTFSEYT VVADISVAKI DPLAPLDKVC LLGCGISTGY
     GAAVNTAKLE PGSVCAVFGL GGVGLAVIMG CKVAGASRII GVDINKDKFA RAKEFGATEC
     INPQDFSKPI QEVLIEMTDG GVDYSFECIG NVKVMRAALE ACHKGWGVSV VVGVAASGEE
     IATRPFQLVT GRTWKGTAFG GWKSVESVPK LVSEYMSKKI KVDEFVTHNL SFDEINKAFE
     LMHSGKSIRT VVKI
//
